Michael J. Farrell net worth and biography

Michael Farrell Biography and Net Worth

CEO of ResMed

Michael “Mick” Farrell was appointed ResMed’s CEO and has served as a director since March 2013. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development.

Before joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at companies including Arthur D. Little, Sanofi Genzyme, Dow Chemical, and BHP.

Mick serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a multibillion dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: the compensation and management development committee, as well as the quality, regulatory & technology committee, where he also serves as Chair. Mick also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, and Father Joe’s Villages’ project for the homeless in San Diego, California.

Mick holds a bachelor of engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management.

What is Michael J. Farrell's net worth?: The estimated net worth of Michael J. Farrell is at least $113.16 million as of October 7th, 2024. Mr. Farrell owns 464,169 shares of ResMed stock worth more than $113,155,119 as of November 23rd. This net worth evaluation does not reflect any other assets that Mr. Farrell may own. Additionally, Mr. Farrell receives an annual salary of $2,920,000.00 as CEO at ResMed. Learn More about Michael J. Farrell's net worth.
How old is Michael J. Farrell?: Mr. Farrell is currently 52 years old. There are 4 older executives and no younger executives at ResMed. Learn More on Michael J. Farrell's age.
What is Michael J. Farrell's salary?: As the CEO of ResMed Inc., Mr. Farrell earns $2,920,000.00 per year. Learn More on Michael J. Farrell's salary.
How do I contact Michael J. Farrell?: The corporate mailing address for Mr. Farrell and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Michael J. Farrell's contact information.
Has Michael J. Farrell been buying or selling shares of ResMed?: During the last quarter, Michael J. Farrell has sold $6,810,269.06 in ResMed stock. Most recently, Michael J. Farrell sold 14,683 shares of the business's stock in a transaction on Monday, October 7th. The shares were sold at an average price of $231.91, for a transaction totalling $3,405,134.53. Following the completion of the sale, the chief executive officer now directly owns 464,169 shares of the company's stock, valued at $107,645,432.79. Learn More on Michael J. Farrell's trading history.
Who are ResMed's active insiders?: ResMed's insider roster includes Carol Burt (Director), Jan De Witte (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.
Are insiders buying or selling shares of ResMed?: In the last twelve months, insiders at the medical equipment provider sold shares 27 times. They sold a total of 187,789 shares worth more than $41,061,987.20. The most recent insider tranaction occured on November, 12th when Director Witte Jan De sold 796 shares worth more than $198,052.76. Insiders at ResMed own 0.7% of the company. Learn More about insider trades at ResMed.
Information on this page was last updated on 11/12/2024.

Michael J. Farrell Insider Trading History at ResMed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/7/2024	Sell	14,683	$231.91	$3,405,134.53	464,169
10/7/2024	Sell	14,683	$231.91	$3,405,134.53	464,169
9/9/2024	Sell	14,683	$248.38	$3,646,963.54	464,169
8/7/2024	Sell	14,683	$214.25	$3,145,832.75	440,799
7/8/2024	Sell	14,683	$192.97	$2,833,378.51	440,799
6/7/2024	Sell	14,683	$211.66	$3,107,803.78	440,799
5/7/2024	Sell	14,683	$216.50	$3,178,869.50	440,752
11/15/2023	Sell	5,678	$152.04	$863,283.12	440,986
10/16/2023	Sell	5,675	$140.70	$798,472.50	449,360
9/15/2023	Sell	5,675	$146.35	$830,536.25	449,360
8/15/2023	Sell	5,675	$183.20	$1,039,660.00	436,930
7/17/2023	Sell	5,675	$221.27	$1,255,707.25	436,930
6/15/2023	Sell	5,675	$217.39	$1,233,688.25	436,930
5/15/2023	Sell	5,675	$232.10	$1,317,167.50	436,930
4/17/2023	Sell	5,675	$224.23	$1,272,505.25	436,900
3/15/2023	Sell	5,675	$206.95	$1,174,441.25	436,900
2/15/2023	Sell	5,675	$214.83	$1,219,160.25	436,900
1/17/2023	Sell	5,675	$224.36	$1,273,243.00	436,900
12/15/2022	Sell	5,675	$215.63	$1,223,700.25	436,900
11/15/2022	Sell	5,675	$224.64	$1,274,832.00	414,024
11/10/2022	Sell	4,880	$220.83	$1,077,650.40	422,654
10/17/2022	Sell	5,675	$214.58	$1,217,741.50	422,570
9/15/2022	Sell	5,675	$228.96	$1,299,348.00	422,570
7/15/2022	Sell	5,675	$224.94	$1,276,534.50	405,260
6/15/2022	Sell	5,675	$202.54	$1,149,414.50	405,260
5/16/2022	Sell	5,675	$196.61	$1,115,761.75	405,260
4/18/2022	Sell	5,675	$232.41	$1,318,926.75	405,229
3/15/2022	Sell	5,675	$242.37	$1,375,449.75
2/15/2022	Sell	5,675	$234.06	$1,328,290.50
1/18/2022	Sell	5,675	$241.94	$1,373,009.50
12/15/2021	Sell	5,675	$255.53	$1,450,132.75
2/10/2020	Sell	6,647	$172.21	$1,144,679.87	361,347
1/13/2020	Sell	6,651	$157.43	$1,047,066.93	361,351
11/26/2019	Sell	1,370	$149.26	$204,486.20	354,700
11/11/2019	Sell	6,651	$143.94	$957,344.94
10/14/2019	Sell	6,651	$129.83	$863,499.33	310,975
9/9/2019	Sell	6,651	$137.38	$913,714.38	310,975
8/12/2019	Sell	6,651	$132.35	$880,259.85	292,988
7/8/2019	Sell	6,651	$123.76	$823,127.76	292,988
6/10/2019	Sell	6,651	$118.16	$785,882.16	292,988
5/13/2019	Sell	6,651	$109.72	$729,747.72
4/8/2019	Sell	6,651	$100.82	$670,553.82	292,933
3/11/2019	Sell	6,651	$101.05	$672,083.55	292,933
2/11/2019	Sell	6,651	$97.18	$646,344.18	288,799
1/14/2019	Sell	6,651	$113.75	$756,551.25	292,933
11/16/2018	Sell	3,300	$104.49	$344,817.00	240,487
10/17/2016	Sell	5,975	$64.25	$383,893.75	203,781
9/15/2016	Sell	5,975	$64.84	$387,419.00
8/15/2016	Sell	5,975	$70.41	$420,699.75
7/15/2016	Sell	5,975	$65.03	$388,554.25	154,814
6/15/2016	Sell	5,975	$59.63	$356,289.25	154,814
5/16/2016	Sell	5,975	$57.64	$344,399.00	154,723
4/15/2016	Sell	5,975	$59.34	$354,556.50	154,723
3/15/2016	Sell	5,975	$58.57	$349,955.75	150,852
2/16/2016	Sell	5,975	$58.20	$347,745.00	144,878
1/15/2016	Sell	5,975	$53.07	$317,093.25	144,878
11/16/2015	Sell	5,975	$57.03	$340,754.25	144,878
10/15/2015	Sell	5,975	$55.35	$330,716.25	172,370
9/15/2015	Sell	5,975	$50.89	$304,067.75	172,370
8/17/2015	Sell	5,975	$55.54	$331,851.50
7/15/2015	Sell	5,975	$57.59	$344,100.25
6/15/2015	Sell	5,975	$57.87	$345,773.25
3/16/2015	Sell	5,975	$69.10	$412,872.50
9/15/2014	Sell	3,200	$52.41	$167,712.00
7/15/2014	Sell	3,200	$49.22	$157,504.00
6/16/2014	Sell	3,200	$53.20	$170,240.00
8/8/2012	Sell	30,000	$35.58	$1,067,400.00

Michael J. Farrell Buying and Selling Activity at ResMed

ResMed Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Today's Range

Now: $243.78

$241.44

$243.89

50 Day Range

MA: $241.86

$231.43

$256.07

2 Week Range

Now: $243.78

$151.95

$260.49

Volume

551,442 shs

Average Volume

1,116,007 shs

Market Capitalization

$35.79 billion

P/E Ratio

32.29

Dividend Yield

0.87%

Beta

0.69

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Michael Farrell Biography and Net Worth

What is Michael J. Farrell's net worth?

How old is Michael J. Farrell?

What is Michael J. Farrell's salary?

How do I contact Michael J. Farrell?

Has Michael J. Farrell been buying or selling shares of ResMed?

Who are ResMed's active insiders?

Are insiders buying or selling shares of ResMed?